Abstract:As we embark on a new year of scientific inquiry in neurodegenerative disease research, it is helpful to take a look back and consider the contributions in the field with the potential to be the most impactful. The purpose of this review is to highlight recent advances in 2019 which have the potential to be transformative in the field of neurodegenerative neuropathology. Substantive scientific progress rarely occurs as a "eureka moment", and when possible, we opted to highlight collaborative efforts and research trends. We also included groundbreaking methodologies and tools. The generous increases in federal funding in the United States and elsewhere have massively expanded the total number of active programs researching Alzheimer's disease. This exacerbates an imbalance, and an effort was made to highlight innovations across disease categories, and not to permit dementia to crowd out movement disorders, motor neuron disease, ataxias, etc. Thus, our overall goal was to highlight some of the most important discoveries, tools or methods that we feel will most likely directly enhance our ability to understand and diagnose neurodegenerative brain diseases. Given space limitations and the targeted readership of this journal, we selected ten topics most relevant to neuropathologists and clinical neuroscientists: 1. A new neurodegenerative disease category, 2. A new approach to probing gene expression on the single cell level, 3. A new approach merging histology and gene expression profiling, 4. A new computational approach using deep machine learning and computer vision, 5. A neuropathological substrate for sleep disturbance in Alzheimer's disease, 6. A candidate pathogenic agent for Alzheimer's disease, 7. A comprehensive approach to morphometric analysis of cerebellar neurodegeneration, 8. The strongest evidence yet linking neurodegeneration to contact sports, 9. Mounting evidence for gut to central nervous system transmission in Parkinson's disease, and 10. A spotlight on glia in Huntington's disease.

The 2020 SLAS Discovery Top 10: Advancing the Science of Drug Discovery

The 2020 SLAS Technology Top Ten: Translating Life Sciences Innovation

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Introduction to the mini special issue on next generation drug discovery and development: rethinking translational pharmacology for accelerated drug development

The 2020 SLAS Technology Ten: Translating Life Sciences Innovation

Science and a global conscience: remaking the world we broke

Drug development post COVID-19 pandemic: toward a better system to meet current and future global health challenges

Molecular insights provide the critical path to disease mitigation

An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters

Current Status of Computational Approaches for Small Molecule Drug Discovery

Top ten discoveries of the year: Neurodegeneration

A brief review on the lessons learned from COVID-19 on drug discovery and research

Discovery in Clinical and Translational Medicine

Importance of scientific collaboration in contemporary drug discovery and development: a detailed network analysis

Drug discovery in the next decade: innovation needed ASAP

Quest for a COVID-19 Cure by Repurposing Small-Molecule Drugs: Mechanism of Action, Clinical Development, Synthesis at Scale, and Outlook for Supply

A comprehensive review of discovery and development of drugs discovered from 2020-2022

Accelerating antiviral drug discovery: lessons from COVID-19

IUPAC Top Ten Emerging Technologies in Chemistry 2021

Vaccine process technology—A decade of progress

Recent Insights for the Emerging COVID-19: Drug Discovery, Therapeutic Options and Vaccine Development